Page 1

Discover Exceptional performance and protection1,2 that Dexcom Continuous Glucose M ­ onitoring delivers. Now in color and better than ever.

LBL-011671 Rev02 G4_HCP Brochure_FINAL.indd 1

10/5/12 3:31 PM

Sleek, slim, and easy to see. The Dexcom G4 PLATINUM CGM System offers a modern design and color LCD screen with vibrant colors so you can easily see glucose highs, lows and everything in between to help manage your patients’ diabetes.

Better than ever. Our new Dexcom G4 PLATINUM sensor packs a punch and delivers even better performance and accuracy 22than ever for dependable results you and your patients can count on.

You’re serious about results, so don’t settle for just any sensor. Choose the one that delivers dynamic glucose patterns, exceptional sensing performance, and software that makes identifying critical patterns quick and easy. Choose Dexcom G4 PLATINUM and see the difference.

LBL-011671 Rev02 G4_HCP Brochure_FINAL.indd 2

10/5/12 3:31 PM

Introducing the Dexcom G4 PLATINUM ™

Continuous Glucose Monitoring System The CGM you’ve been waiting for has finally arrived! Color CGM

20-Foot Range

3 Faceplate Colors

Easy to read and identify glucose highs and lows.

3x farther than the next available brand with 97% of expected sensor data captured.2,5

Tickled Pink Classic Black

Touch of a ButtonTM Glucose trend on demand.

Ocean Blue

Customized Alarms Alert profiles with tones and melodies to suit your individual needs wherever you are.

LBL-011671 Rev02 G4_HCP Brochure_FINAL.indd 3

Dexcom G4 PLATINUM Continuous Glucose Monitoring System

10/5/12 3:32 PM

How Continuous Glucose Monitoring can help patients make healthy, confident, and well-informed decisions.

Fingersticks alone can only alert you to patterns when you have tested. But with CGM, you’ll see where glucose is heading and how fast it’s getting there. With the Dexcom G4 PLATINUM, you can coach your patients to make informed decisions in the short-term while mapping a pathway for long-term better health.

CGM Lowers A1Cs without increasing hypoglycemia 8.0 P <.001


7.5 A1c (%)

Whether you’re trying to lower your patients’ A1c, reduce their number of hypo incidents, or keep them out of the ER, Dexcom Continuous Glucose Monitoring (CGM) gives your patients a complete and real time picture of their glucose levels to help avoid these events 3.

7.0 Control


6.5 Baseline

13 weeks

26 weeks

Significant Decrease in A1c in Patients Aged 25 Years *Error bars stand for 95% Cl. JDRF Continuous Glucose Monitoring Study Group. N Engl J Med. 2008;359(14):1464-1476

Widespread Coverage for CGM

The majority of commercial insurances have medical policy to cover CGM. Dexcom can investigate insurance coverage for your patients.

LBL-011671 Rev02 G4_HCP Brochure_FINAL.indd 4

10/5/12 3:32 PM

Fingersticks show current glucose, but do your patients know where their glucose is heading?

If this is the meter reading, what would your patients do?


If your patients saw this instead, would they have responded differently?

If this is the meter reading, what would your patients do?


If your patients saw this instead, would they have responded differently?

Same number. Different decisions. Get the assurance of real time data in vivid colors that only Dexcom G4 PLATINUM CGM can provide.

LBL-011671 Rev02 G4_HCP Brochure_FINAL.indd 5

10/5/12 3:32 PM

Setting an even higher standard in CGM When LOWER is better

When it comes to accuracy, Dexcom’s Sensor Geometry, Membrane Technology, and Algorithm are what set us apart. Our commitment to continuously improve our technology enables us to deliver exceptional sensing performance. The results speak for themselves.

Overall Accuracy

Sensor to Sensor Variation

Mean/Average ARD % (MARD) 40-400 mg/dL Dexcom G4TM PLATINUM2


Brand M5



Brand M5







Hypoglycemia Detection Rate at 70mg/dL

When HIGHER is better

(% of time BG level at/below alert setting and alert sounded within 15 minutes before or after BG value was 70mg/dL)

Hypoglycemia Accuracy (%20/20)* When BG is between 40-80 mg/dL



Brand M5



Brand M5







Accuracy Over Time

Sensor Life

(%20/20)* Overall between 40-400mg/dL

(up to indicated use)



Brand M5

Day 1: 71% Day 4: 87% Day 7: 87%

Day 1: 77% Day 4: 80% Day 7: 70%

Day 1: 81% Day 2: 65% Day 3: 41%

Avg Daily Calibration: 2x/day

Avg Daily Calibration: 2x/day

Avg Daily Calibration: 3.5x/day



Brand M5




(7 day sensor)

(7 day sensor)

(3 day sensor)

Metrics presented are values rounded to the nearest whole number. *% of glucose readings within 20% of reference YSI when >80mg/dL or within 20mg/dL when ≤80mg/dL.

Your patients will thank you DELIVER DISCRETION  A sleek and slim Receiver profile plus ear-pleasing tones or melodies so your patients can customize their alerts and alarms to suit different environments.

DELIVER COMFORT  With a sensor needle that’s more than 1/3 smaller 6 than the next available brand, it’s easy to see why Dexcom is often cited as the most comfortable sensor to wear.

DELIVER A SENSOR THAT FITS THEIR LIFESTYLE  Dexcom is the only sensor on the market that’s approved for up to 7 days2,4 of wear for added value and patient convenience. 2009



LBL-011671 Rev02 G4_HCP Brochure_FINAL.indd 6

Dexcom consistently ranked highest in customer loyalty 3 years in a row.7

10/5/12 3:32 PM

The difference is Dexcom Software that easily and quickly identifies critical patterns

Enhanced features

New features


Menu navigation

New pre- and post-meal glucose range customization Dexcom PORTRAIT™ — the report that says it all!


Advanced QUICK PRINT ™ Feature

• One page report • May help validate and prioritize therapy changes • Complete CGM interpretation documentation

Downloads in seconds


DAILY STRIP PRINT ™ for integrated event details with one click

Sensor of choice

Going beyond

No matter what your patients’ choice of insulin delivery, CGM can benefit patients on multiple daily injections just as significantly as those on insulin pumps8.

Dexcom is the first to develop a CE Marked in-vivo, Automated Blood Glucose Monitoring System in partnership with Edwards Lifesciences for use in the critical care environment.

If your patient pumps, Dexcom G4 PLATINUM can be used to complement their insulin pump to help fine-tune their insulin delivery therapy.

In the Artificial Pancreas arena, Dexcom CGM is a proud partner in the JDRF AP and the European AP@Home studies — with 70% of AP projects 10 using Dexcom’s CGM technology.

Pump Brands

Insulin Brands


Eli Lilly


Novo Nordisk



Tandem Diabetes Care Medtronic9

LBL-011671 Rev02 G4_HCP Brochure_FINAL.indd 7

See for yourself what sets us apart and experience the difference that is Dexcom. Contact us today at (888) 738-3646 / (858) 200-0200 or visit to discover more.

10/5/12 3:32 PM

BRIEF SAFETY STATEMENT The Dexcom G4 PLATINUM Continuous Glucose Monitoring System is a glucose monitoring device indicated for detecting trends and tracking patterns in persons (age 18 and older) with diabetes. CONTRAINDICATIONS: Remove the Dexcom G4 PLATINUM System before MRI, CT scan, or diathermy treatment. Taking acetaminophen while wearing the sensor may falsely raise your sensor glucose readings. WARNING: Do not use the Dexcom G4 PLATINUM for treatment decisions. The Dexcom G4 PLATINUM does not replace a blood glucose meter. If a sensor breaks and no portion of it is visible above the skin, do not attempt to remove it. Seek professional medical help if you have infection or inflammation. Report broken sensors to Dexcom Technical Support. The Dexcom G4 PLATINUM is not approved for use in children or adolescents, pregnant women or persons on dialysis. Sensor placement is not approved for sites other than under the skin of the belly (abdomen). Contact Dexcom Toll Free at 877339-2664 or for detailed indications for use and safety information. Š2012 Dexcom Inc. All rights reserved. This product is covered by US patent. DEXCOM, THE GLUCOSE SENSOR COMPANY, DEXCOM G4 PLATINUM, DEXCOM STUDIO, DEXCOM PORTRAIT, DEXCOM MAKES SENSE., DAILY STRIP PRINT, DESIGNED FOR EXCEPTIONAL SENSING, QUICK PRINT, SMART.SIMPLE.SENSE., and TOUCH OF A BUTTON are trademarks and registered trademarks of Dexcom, Inc. All trade dress used in connection with Dexcom products and services appearing herein are property of Dexcom and protected by United States and foreign trademark laws. All other trademarks and registered trademarks are the property of their respective owners.

References: Polonsky W, Hessler D, Bowman F, Price D. Impact of CGM use on Quality of Life (QoL): A survey of current users. ADA Poster, June 2012.

1 2

Dexcom G4 PLATINUM User Guide, 2012.


Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes. N Engl J Med. 2008:359(14):1464-1476.


Dexcom SEVEN PLUS User Guide, 2008.


Medtronic Paradigm REAL-Time Revel manufacturer User Guide, 2009.

6, Product Reference Guide, 2010; Caliper measurements: Dexcom 0.018, Medtronic 0.028, measurements are in 1/1000th inches, May 2011.


dQ&A market research study, 2009-2012.


Rodbard D, Jovanovic L, Garg SK. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diab Tech Ther. 2009;11:757-763


1 in 4 Dexcom users on pumps use Medtronic, Dexcom customer survey, April 2012


Internal data on file, May 2012.

To locate your local Dexcom representative, call (888) 738-3646

Customer Care: (888) 738-3646 Dexcom Inc. | Corporate Headquarters 6340 Sequence Drive San Diego, CA 92121 (858) 200-0200

LBL-011671 Rev02 G4_HCP Brochure_FINAL.indd 8

LBL-011671 Rev02 MT 21924

10/5/12 3:32 PM

HCP Brochure  

Healthcare professional brochure for Dexcom G4 PLATINUM CGM system

HCP Brochure  

Healthcare professional brochure for Dexcom G4 PLATINUM CGM system